Page last updated: 2024-11-06

floxuridine and Adenocarcinoma, Mucinous

floxuridine has been researched along with Adenocarcinoma, Mucinous in 7 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"With a diagnosis of advanced breast cancer with skin invasion, she underwent right mastectomy with a free skin graft."1.32Massive mucinous carcinoma of the breast untreated for 6 years. ( Sakaguchi, K; Tsuchie, K; Yoneyama, F, 2003)
" Pharmacokinetic studies after administration of S-1 revealed high and prolonged plasma 5-FU levels."1.32S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study. ( Ajani, JA; Itoh, N; Itoi, H; Shirasaka, T; Ueda, Y; Yamagishi, H; Yamashita, T, 2004)
"The overall response rate was 20."1.28[Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer]. ( Ikeda, M; Noda, K; Ochiai, K; Saito, Y; Sato, A; Suzuki, M; Takada, M; Terashima, Y; Yajima, A; Yoshida, K, 1991)
" 5'-DFUR was administered three or four times a day at a daily dosage of 600 to 1200 mg."1.27[Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group]. ( Gocho, Y; Ishitani, K; Kogo, Y; Kouda, K; Koyama, R; Matsuda, M; Nagai, T; Niitsu, Y; Saijo, N; Urushizaki, I, 1985)
" 5'-DFUR (5'-deoxy-5-fluorouridine) was administered orally at 1,200 mg/day for 23 weeks, for a total dosage of 110."1.27[A case of gastric cancer in which long-term administration of 5'-deoxy-5-fluorouridine (5'-DFUR) proved effective]. ( Iwao, N; Koda, T; Kurahori, T; Miyaji, J; Okahisa, N; Sonoda, T; Sumi, S; Yanagimoto, H, 1987)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wagner, PL1
Jones, D1
Aronova, A1
Shia, J1
Weiser, MR1
Temple, LK1
Chung, KY1
O'Reilly, EM1
Kelsen, D1
Paty, PB1
Nash, GM1
Yoneyama, F1
Tsuchie, K1
Sakaguchi, K1
Ueda, Y1
Yamagishi, H1
Yamashita, T1
Itoh, N1
Itoi, H1
Shirasaka, T1
Ajani, JA1
Tanaka, K1
Noura, S1
Ohue, M1
Takachi, K1
Kishi, K1
Eguchi, H1
Yamada, T1
Miyashiro, I1
Yano, M1
Ohigashi, H1
Sasaki, Y1
Ishikawa, O1
Imaoka, S1
Kameyama, M1
Murata, K1
Noda, K1
Ikeda, M1
Saito, Y1
Yajima, A1
Sato, A1
Suzuki, M1
Terashima, Y1
Ochiai, K1
Yoshida, K1
Takada, M1
Urushizaki, I1
Kogo, Y1
Kouda, K1
Ishitani, K1
Niitsu, Y1
Matsuda, M1
Gocho, Y1
Koyama, R1
Nagai, T1
Saijo, N1
Koda, T1
Kurahori, T1
Iwao, N1
Sumi, S1
Sonoda, T1
Yanagimoto, H1
Miyaji, J1
Okahisa, N1

Other Studies

7 other studies available for floxuridine and Adenocarcinoma, Mucinous

ArticleYear
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis.
    Diseases of the colon and rectum, 2012, Volume: 55, Issue:4

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N

2012
Massive mucinous carcinoma of the breast untreated for 6 years.
    International journal of clinical oncology, 2003, Volume: 8, Issue:2

    Topics: Adenocarcinoma, Mucinous; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Floxurid

2003
S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study.
    Japanese journal of clinical oncology, 2004, Volume: 34, Issue:5

    Topics: Adenocarcinoma, Mucinous; Administration, Oral; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv

2004
[A case of chemoradiation with tissue expander for local reccurence of rectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11

    Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antine

2005
[Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:15

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Antineoplastic Agents;

1991
[Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:12

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colo

1985
[A case of gastric cancer in which long-term administration of 5'-deoxy-5-fluorouridine (5'-DFUR) proved effective].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:8

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Female; Floxuridine; Humans; Long-Term Care; Middle

1987